Intestinal Wall Remodeling (Infliximab Therapy) in Crohn's Disease Patients Undergoing Serial Computed Tomography (CT) Enterography

Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

NCT05906576 ·Status: RECRUITING ·Phase: PHASE4

Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)

NCT01349920 ·Status: COMPLETED

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

NCT05230173 ·Status: RECRUITING ·Phase: NA

A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease

NCT04312659 ·Status: COMPLETED

Immune Regulation in Ulcerative Colitis or Crohn s Disease

NCT00001184 ·Status: RECRUITING

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

NCT00325078 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

NCT03801928 ·Status: COMPLETED

The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients

NCT02330458 ·Status: UNKNOWN

Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn's Disease Patients

NCT00676988 ·Status: COMPLETED

Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)

NCT01289366 ·Status: COMPLETED

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

NCT00269854 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

NCT05781152 ·Status: RECRUITING ·Phase: PHASE4

Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)

NCT00805766 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel

NCT00587210 ·Status: COMPLETED

A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

NCT00207675 ·Status: COMPLETED ·Phase: PHASE3

CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease

NCT01183403 ·Status: COMPLETED

Biomarkers to Predict and Monitor Response to Infliximab

NCT04655729 ·Status: UNKNOWN

Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel Disease

NCT00586352 ·Status: COMPLETED ·Phase: NA

A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis

NCT05579392 ·Status: RECRUITING ·Phase: NA

Crohn's Disease Stem Cell Transplantation

NCT00271947 ·Status: TERMINATED ·Phase: PHASE2

Treatment and Fate in Fistulizing Crohn's Disease in a Pediatric Population

NCT05759104 ·Status: UNKNOWN

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

NCT06252493 ·Status: RECRUITING

Treatment With Infliximab in a Medical Setting (Study P05587)

NCT00752622 ·Status: TERMINATED ·Phase: PHASE4

The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.

NCT06006039 ·Status: RECRUITING

HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease

NCT05813860 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4